PeopleBio Co., Ltd. (304840) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for PeopleBio Co., Ltd. (304840:KRX), powered by AI.

Current Price
₩978
P/E Ratio
-1.9
Market Cap
20.8B
Sector
Common Stock
What is the PeopleBio Co., Ltd. stock price forecast?

PeopleBio Co., Ltd. is currently trading at ₩978. View real-time AI analysis on Alpha Lenz.

What is PeopleBio Co., Ltd. insider trading activity?

View the latest insider trading data for PeopleBio Co., Ltd. on Alpha Lenz.

What is PeopleBio Co., Ltd.'s P/E ratio?

PeopleBio Co., Ltd.'s P/E ratio is -1.9.

PeopleBio Co., Ltd.

KRX · 304840
₩978
Ask about PeopleBio Co., Ltd.'s future dividend policy...
Alpha Chat Insight

PeopleBio Co., Ltd. trades at a P/E of -1.9 (undervalued) with modest ROE of -79.2%. 3Y revenue CAGR of 86.3% highlights clear growth momentum.

Ask for details

Company Overview

PeopleBio Co., Ltd. is a biotechnology company primarily engaged in research and development within the medical diagnostics industry. The company focuses on developing advanced diagnostic technologies, particularly in the fields of neurodegenerative diseases and cancer detection. PeopleBio is renowned for its innovative methods in protein misfolding cyclic amplification and multiplex detection systems, which are designed to improve early diagnosis of critical diseases like Alzheimer's. By emphasizing early detection, PeopleBio contributes significantly to improving patient outcomes and potentially reducing the long-term costs of healthcare. The company's products are crucial for healthcare providers, laboratories, and research institutions across various regions, facilitating more accurate and faster diagnoses. Operating in a rapidly evolving biotechnological landscape, PeopleBio plays a critical role in advancing medical diagnostics and bringing enhanced precision and reliability to clinical testing services globally.

CEO강성민
SectorCommon Stock
IndustryCommon Stock
0

Company Statistics

FY 2024

Profile

₩20,761,288,158Market Cap
₩3,731,509,680Revenue
21.23MShares Out
0Employees

Margins

36.22%Gross
-282.25%EBITDA
-308.22%Operating
-326.22%Pre-Tax
-326.22%Net

Valuation

-1.95P/E
2.53P/B
5.70EV/Sales
-2.70EV/EBITDA
-1.93P/FCF

Growth (CAGR)

86.30%Rev 3Yr
33.05%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-44.54%ROA
-79.18%ROE
-40.63%ROIC

Financial Health

₩1,261,746,120Cash & Cash Equivalents
₩18,192,196,920Net Debt
255.28%Debt/Equity
N/AInterest Cov
Alpha Chat Insight

PeopleBio Co., Ltd. trades at a P/E of -1.9 (undervalued) with modest ROE of -79.2%. 3Y revenue CAGR of 86.3% highlights clear growth momentum.

Ask for details

Frequently Asked Questions

PeopleBio Co., Ltd. (ticker: 304840) is a company listed on KRX in the Common Stock sector (Common Stock). Market cap is $20.8B.

The current price is ₩978 with a P/E ratio of -1.95x and P/B of 2.53x.

ROE is -79.18% and operating margin is -308.22%. Annual revenue is $3.7B.

Alpha Lenz
Singapore
CEO: Kyungtae Kim | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2025 Treasurer. All rights reserved.
PeopleBio Co., Ltd. (Common Stock) Stock Forecast & Analysis ₩978 | Alpha Lenz